Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert J de Winter

Showing results (341-350 of 467) with videos related to

Pageof 47
Sort By:
Circulation. Cardiovascular Interventions|November 2, 2017
Efficacy of the RADPAD Protection Drape in Reducing Operators' Radiation Exposure in the Catheterization Laboratory: A Sham-Controlled Randomized TrialWieneke Vlastra, Ronak Delewi, Krischan D Sjauw, et al.
American Heart Journal|January 21, 2014
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study designPier Woudstra, Maik J Grundeken, Robin P Kraak, et al.
International Journal of Cardiology|May 9, 2013
Additional side branch stent placement in patients with long side branch lesions treated with the Tryton dedicated bifurcation side branch stentMaik J Grundeken, Pieter R Stella, Armando Bethencourt, et al.
European Journal of Clinical Investigation|March 19, 2016
Older coronary thrombus is an independent predictor of 1-year mortality in acute myocardial infarctionXiaofei Li, Miranda C Kramer, Peter Damman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 31, 2019
Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE RegistryLaura S Kerkmeijer, Deborah N Kalkman, Pier Woudstra, et al.
Plos One|May 3, 2014
Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarctionPier Woudstra, Peter Damman, Wichert J Kuijt, et al.
International Journal of Cardiology|April 26, 2018
Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysisLaura S Kerkmeijer, Bimmer E Claessen, Usman Baber, et al.
Stroke Research and Treatment|July 27, 2011
Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and MortalityStella Trompet, Douwe Pons, Sandip M Kanse, et al.
Diabetes Care|March 29, 2005
Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary interventionJamal S Rana, Pascalle S Monraats, Aeilko H Zwinderman, et al.
JACC. Cardiovascular Interventions|June 6, 2016
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II TrialPannipa Suwannasom, Yohei Sotomi, Yuki Ishibashi, et al.
Pageof 47

Showing results (341-350 of 467) with videos related to

Sort By:
Pageof 47
Circulation. Cardiovascular Interventions|November 2, 2017
Efficacy of the RADPAD Protection Drape in Reducing Operators' Radiation Exposure in the Catheterization Laboratory: A Sham-Controlled Randomized TrialWieneke Vlastra, Ronak Delewi, Krischan D Sjauw, et al.
American Heart Journal|January 21, 2014
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study designPier Woudstra, Maik J Grundeken, Robin P Kraak, et al.
International Journal of Cardiology|May 9, 2013
Additional side branch stent placement in patients with long side branch lesions treated with the Tryton dedicated bifurcation side branch stentMaik J Grundeken, Pieter R Stella, Armando Bethencourt, et al.
European Journal of Clinical Investigation|March 19, 2016
Older coronary thrombus is an independent predictor of 1-year mortality in acute myocardial infarctionXiaofei Li, Miranda C Kramer, Peter Damman, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 31, 2019
Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE RegistryLaura S Kerkmeijer, Deborah N Kalkman, Pier Woudstra, et al.
Plos One|May 3, 2014
Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarctionPier Woudstra, Peter Damman, Wichert J Kuijt, et al.
International Journal of Cardiology|April 26, 2018
Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysisLaura S Kerkmeijer, Bimmer E Claessen, Usman Baber, et al.
Stroke Research and Treatment|July 27, 2011
Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and MortalityStella Trompet, Douwe Pons, Sandip M Kanse, et al.
Diabetes Care|March 29, 2005
Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary interventionJamal S Rana, Pascalle S Monraats, Aeilko H Zwinderman, et al.
JACC. Cardiovascular Interventions|June 6, 2016
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II TrialPannipa Suwannasom, Yohei Sotomi, Yuki Ishibashi, et al.
Pageof 47